Enzyme Protocol Welcomes New Vaults

Enzyme Protocol announces strategic positioning as the infrastructure catalyst for tokenized finance, emphasizing its role in enabling transformation without being the center of attention. Key features: - Modular system supporting cross-chain execution, custom design, and automation - Vault-as-a-Service and Onchain Options Protocol offerings - Focus on security and scalability for institutions, asset managers, and DAOs The protocol aims to provide the foundational infrastructure for tokenized finance while maintaining user-friendly interfaces despite complex backend operations. Learn more at [Enzyme Finance](https://enzyme.finance)

Enzyme.Myso is advancing DeFi with institutional-grade on-chain options trading. The platform offers: - Native on-chain options strategies - Fully auditable transaction flows - Infrastructure designed for DAOs and institutions **Real-world implementation**: Compound DAO recently integrated covered calls into their treasury strategy using Enzyme.Myso, targeting approximately 15% APY while maintaining controlled risk exposure. This development signals a shift in how DAOs can optimize idle capital through sophisticated options strategies. *Learn more at* [Enzyme Finance](http://enzyme.finance/products/myso)

Major financial institutions are forecasting significant growth in tokenized assets: - Citi projects tokenized securities market could reach $45T by 2030 - WEF estimates 10% of global GDP could be blockchain-tokenized by 2027 - McKinsey reports shift from pilot to at-scale deployment Key trends expected in next cycle: - Shift to natively tokenized funds - Increased institutional adoption - Integration with DeFi infrastructure - Clearer regulatory framework Traditional finance faces challenges from outdated systems, while tokenized vehicles offer programmability and global accessibility. Enzyme Protocol is positioning to support this transition with native tokenization capabilities. [Learn more about tokenized funds](http://enzyme.finance/use-cases/tokenized-funds)

Real-world assets (RWAs) tokenized on blockchain have reached a significant milestone, surpassing $10B in Total Value Locked (TVL). This marks a crucial shift in how traditional assets are being brought on-chain. Key developments: - Over $18B in assets now tokenized (excluding stablecoins) - Infrastructure development becoming priority for operational use - Integration possibilities include RWA funds, ETPs, and indices Enzyme Protocol enables users to leverage these tokenized assets within investment strategies, marking a practical step toward mainstream RWA adoption. Learn more about tokenized asset infrastructure: [Chainlink's Guide](https://blog.chain.link/definitive-guide-to-tokenized-assets/)

Enzyme Protocol marked significant expansion in 2024 with key developments: - Acquired Myso Finance, the leading on-chain covered calls protocol - Invested in Trade Neutral to expand services to Solana ecosystem - Extended protocol to Arbitrum and integrated GMX - Launched first Advanced Automated Loops with Stader Labs - Reached $220M in Assets Under Technology with 1,400+ creations 2025 roadmap focuses on: - Completing Solana integration - Expanding to additional networks - Launching V5 protocol update - Strengthening global infrastructure position The protocol has maintained steady growth since its 2017 launch as Melon Protocol, navigating market cycles while expanding capabilities.